Author | Secondary outcomes | ||||||||
Fasting glucose level | 2-hour plasma glucose | HbA1c (%) | |||||||
Intervention | Control | Intervention | Control | Intervention | Control | ||||
Mean (mmol/L)/mean change±SD | Mean (mmol/L)/mean change±SD | P value | Mean (mmol/L)/mean change±SD | Mean (mmol/L)/mean change±SD | P value | Mean/mean change±SD | Mean/ mean change±SD | P value | |
Kavumpurathu R Thankappan et al33 | 0.225±0.811 | 0.23±0.988 | 0.79 | 0.43±1.97 | 0.47±2.11 | 0.63 | –0.003±0.43 | 0.056±0.603 | 0.08 |
Xia Dai et al34 | AT: 5.40±0.56 RT: 5.52±0.57 AT+RT: 5.08±0.46 | 6.59±0.57 | - | AT: 7.48±1.37 RT: 7.17±1.31 AT+RT: 6.85±1.78 | 8.26±0.97 | 0.007 | AT: 5.80±0.39 RT: 5.46±0.50 AT+RT: 5.52±0.46 | 6.53±0.75 | <0.001 |
Arpana Gaddam et al35 | Mean: 99.7±11.4 | Mean: 100.6±11.04 | <0.005 | Mean: 129±29.6 | Mean:147.3±32.6 | <0.01 | - | - | - |
Shaahin Shahbazi et al36 | HMD: −1.6±8.2 NFD: −1.4±7.9 | 4.3±10.7 | 0.001 | HMD: −3.9±16.5 NFD: −0.6±17.7 | 3.3 ± 14.8 | 0.005 | - | - | - |
AT, aerobic training; BMI, body mass index; HbA1c, glycated haemoglobin; HMD, high-monounsaturated fat diet; NFD, normal fat diet; NS, non-significant; RT, resistance training.